Rainbow Children's Medicare (RAINBOW) Fundamentals 2026 — P/E 54.4x, Revenue Analysis | SniperIQ
Rainbow Children's Medicare (RAINBOW) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹15,132 Crore, trading at ₹1490.25 on the BSE. This SniperIQ fundamentals page covers Rainbow Children's Medicare's valuation (P/E 54.4x, P/B 9.2x), profitability (net margin 16.3%), revenue (₹1,703 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Rainbow Children's Medicare's market cap?
Rainbow Children's Medicare (RAINBOW) has a market capitalization of approximately ₹15,132 Crore, trading at ₹1490.25 on the BSE. Market cap moves with the live share price.
What is Rainbow Children's Medicare's P/E ratio?
Rainbow Children's Medicare's trailing twelve-month P/E ratio is 54.4x, with a price-to-book (P/B) of 9.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Rainbow Children's Medicare?
Rainbow Children's Medicare runs a net profit margin of 16.3%, a gross margin of 39.5%, and an operating margin of 23.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Rainbow Children's Medicare generate?
Rainbow Children's Medicare reported revenue of ₹1,703 Crore for fiscal year 2026, with net income of ₹278 Crore and earnings per share (EPS) of 27.41. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Rainbow Children's Medicare pay a dividend?
Rainbow Children's Medicare offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Rainbow Children's Medicare financially healthy?
Rainbow Children's Medicare carries a debt-to-equity ratio of 0.54x and a current ratio of 3.59x, with a market beta of 0.17. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Rainbow Children's Medicare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Rainbow Children's Medicare (RAINBOW) the key facts are: market cap ₹15,132 Crore, P/E 54.4x, revenue ₹1,703 Crore, 52-week range 1008.75-1644.1. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Rainbow Children's Medicare's full fundamentals live
Get Rainbow Children's Medicare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.